Health Care/Hospital

Xiao-I Partners with Global Leader in Health Technology to Enhance Knowledge Management with AI Solutions

SHANGHAI, June 6, 2024 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI) ("Xiao-I" or the "Company"), a leading AI company, announces a contract is secured from a renowned multinational conglomerate in the health technology sector base inChina. This contract is set to revolutionize knowledge mana...

2024-06-06 20:01 4051

MicuRx: Successful Completion of Phase I Clinical Trial for Self-Developed MRX-8 Antibacterial Drug in China

* According to the World Health Organization (WHO), millions of patients face treatment difficulties or even life-threatening conditions due to resistant bacterial infections each year. * MRX-8 not only shows excellent safety and tolerability but also demonstrates strong antibacterial activit...

2024-06-06 19:52 1859

I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer

ROCKVILLE, Md., June 6, 2024  /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced the appointment of...

2024-06-06 19:00 1465

Insgeek Champions Digital Transformation in Group Insurance at ITC Asia 2024

SINGAPORE, June 6, 2024 /PRNewswire/ -- Insgeek , a leading player in digital insurance, participated in theInsureTech Connect Asia 2024 (ITC Asia 2024) in Singapore. The event, held fromJune 4th to 6th in Singapore, convened insuran...

2024-06-06 18:42 3648

Waterdrop Inc. Reports 2024 Q1 Revenue of RMB 704.7 Million, net profit rises 62.2% year-on-year, Sustaining Profitability for Nine Consecutive Quarters

BEIJING, June 6, 2024 /PRNewswire/ -- On June 5, Waterdrop Inc. (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare services with a positive social impact, unveiled its unaudited financial results for the first quarter of 2024 endedMarch 31, 2024. During the quarter, ...

2024-06-06 18:07 4237

NDA for Luye Pharma's Rivastigmine Twice Weekly Transdermal Patch Filed in Japan for Treating Alzheimer's Dementia

TOKYO, June 6, 2024 /PRNewswire/ -- Luye Pharma Group announced that its partner Towa Pharmaceutical Co., Ltd. (Towa) has filed a New Drug Application (NDA) to the Ministry of Health, Labour and Welfare (MHLW) inJapan for the Rivastigmine Twice Weekly Transdermal Patch for treating mild to modera...

2024-06-06 17:33 2539

MGI Tech Launches Whole Workflow Solution for Agricultural Large-Scale Low-pass Whole Genome Sequencing at PAG Asia 2024

SHENZHEN, China, June 6, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, today announced a highly efficient whole workflow solution for agricultural large-scale Low-pass whole genome sequencing (Lo...

2024-06-06 17:00 2075

ECHO IQ TECHNOLOGY CHAMPIONED IN INDEPENDENT SCIENTIFIC REVIEW

Echo IQ's EchoSolv-AS decision-support software for cardiology delivers significant potential benefits to hospital networks according to independent scientific presentation at prestigious New York Valves scientific conference. NEW YORK, June 6, 2024 /PRNewswire/ -- At the Structural Heart Summit ...

2024-06-06 13:14 1713

Telehealth System Featuring Rokid Glass 2 Wins HHS Award

HANGZHOU, China, June 5, 2024 /PRNewswire/ -- Rokid's augmented reality (AR) devices are making significant inroads into the medical sector. Utilizing the industrial-grade, split monocular waveguide AR glasses Rokid Glass 2, Rokid's Partner Company has developed a remote diagnostic and therapeuti...

2024-06-06 11:36 1662

Alphamab Oncology Collaborated with ArriVent in relation to the Research, Development and Commercialization of ADC Products

SUZHOU, China, June 6, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Alphamab"), a wholly-owned subsidiary of the Company, entered into a research and collaboration agreement (the "Collaboration Agreement") with ArriVen...

2024-06-06 10:21 2114

Zepp Health's Amazfit Adds US Olympic Medalist Morgan Pearson and Italian National Endurance Icon Yemaneberhan Crippa to Team Amazfit Roster of Athlete Ambassadors

* Amazfit smartwatches and fitness wearables continue to unlock potential for endurance athletes with unparalleled performance benefits MILPITAS, Calif., June 5, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health") (NYSE: ZEPP), a global leader in smart wearables and health technology, ...

2024-06-06 06:04 1720

Regor to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

CAMBRIDGE, Mass., June 5, 2024 /PRNewswire/ -- Regor Therapeutics Group, a clinical-stage global biopharmaceutical company, today announced the Company will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Thursday, June 12. Dr.Xiayang Qiu, Founder and CEO, will rep...

2024-06-05 23:36 1411

STRENGTHENING PATIENT CARE AND SAFETY IN COMPLEX, HIGH-RISK PAEDIATRIC LIVER TRANSPLANT SURGERY

Innovative mixed reality technology enhances pre-surgical planning at NUH's specialised paediatric organ transplant centre inSingapore SINGAPORE, June 5, 2024 /PRNewswire/ --  For the last three decades, the transplant team at theNational University Hospital (NUH)'s Department of Paediatric Surg...

2024-06-05 22:00 2035

Pricing plan from Done aims to make diagnosis and treatment of ADHD more accessible and affordable

SAN FRANCISCO, June 5, 2024 /PRNewswire/ -- Healthcare can be a significant financial burden on many individuals and families, even with insurance. The costs associated with one of the more common health issues in the US, the diagnosis and treatment of adult ADHD, can spill over into many aspects...

2024-06-05 22:00 1991

RemeGen Showcases Research Results at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting, Highlighting Its Prolific Innovation in Global Cancer Treatment

YANTAI, China, June 5, 2024 /PRNewswire/ -- RemeGen Co., Ltd.  ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, showcased its innovation in the field of global cancer treatment at the American Society of Clinical Oncology Annu...

2024-06-05 21:42 2436

Sunway Medical Centre retains Malaysia's top spot in Paediatrics, according to latest Newsweek rankings

The hospital is also ranked highly in the areas of Oncology, Neurology, Neurosurgery, Cardiology, and Cardiac Surgery. SUNWAY CITY, Malaysia, June 5, 2024 /PRNewswire/ -- Sunway Medical Centre (SMC), Sunway City, the flagship quaternary hospital under the Sunway Healthcare Group, retained its to...

2024-06-05 20:00 2509

Oricell Presented Long-term Follow-up Data of OriCAR-017 in RRMM at 2024 ASCO Annual Meeting, Highlighting the Sustained Efficacy of GPRC5D CAR-T Therapy

SHANGHAI and ROSELAND, N.J., June 5, 2024 /PRNewswire/ -- Oricell Therapeutics, a pioneering clinical-stage biopharmaceutical company, has presented the two-year long-term follow-up results of OriCAR-017, an open-label Phase I study evaluating GPRC5D-targeted CAR-T therapy in patients with relaps...

2024-06-05 19:59 2048

I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers

* I-Mab enters clinical collaboration with Bristol Myers Squibb to evaluate Claudin 18.2 x 4-1BB bispecific antibody givastomig in combination with nivolumab and chemotherapy for the treatment of gastric and esophageal cancer. * Collaboration builds on promising safety and efficacy data from t...

2024-06-05 19:00 1513

Crisis24 Combines Elite Concierge Medical Practice and Personal Protection Services to Form new Crisis24 Private Strategic Group division

Delivers "head of state" experience in personal protection and elite supplemental medical concierge services to world's most influential people, disruptive brands,and prominent organizations.  BOCA RATON, Fla., June 5, 2024 /PRNewswire/ -- Crisis24, a GardaWorld company, and a global leader in i...

2024-06-05 19:00 1433

FDA Approved Phase II/III Clinical Study of KPG-121 in Combination with Abiraterone as a First Line Treatment for mCRPC

HEFEI, China, June 5, 2024 /PRNewswire/ -- Kangpu Biopharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has recently approved a Phase II/III clinical trial of KPG-121 in combination with Abiraterone for a first-line treatment of metastatic castration resistant prost...

2024-06-05 19:00 1703
1 ... 76777879808182 ... 847

Week's Top Stories